sitagliptin
UkraineDrugs containing this active substance
-
The drug is intended for adults with type 2 diabetes mellitus to improve blood sugar control. It is used as an adjunct to diet and physical exercise when metformin monotherapy does not provide sufficient results, or in combination with other drugs (insulin, sulfonylurea, etc.).
Form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 500 mg ATC: A10BD07
Manufacturer: Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, testing at release, batch release authorization)
-
The drug is intended for adults with type 2 diabetes to improve blood sugar control. It is used as an adjunct to diet and exercise when other agents (e.g., metformin alone) are insufficient, or in combination with insulin or other antidiabetic medications.
Form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 850 mg ATC: A10BD07
Manufacturer: Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, testing at release, batch release authorization)
-
The drug is intended for adults with type 2 diabetes mellitus to improve blood sugar control. It is used as an adjunct to diet and physical exercise when other agents (e.g., metformin alone) are insufficient, or in combination with insulin or other antidiabetic drugs.
Form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 1000 mg ATC: A10BD07
Manufacturer: Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, testing at release, batch release authorization)
-
The drug is intended for adults with type 2 diabetes to improve blood sugar control. It can be used either as monotherapy or in combination with other medications (e.g., metformin, sulfonylurea, or insulin).
Form: tablets, film-coated
Active substance Dosage sitagliptin 100 mg ATC: A10BH01
Manufacturer: Merck Sharp & Dohme B.V. (Batch release, testing at release)
-
The drug is intended for adults with type 2 diabetes to improve blood sugar control. It can be used either as monotherapy or in combination with other medications (e.g., metformin, insulin, or sulfonylurea).
Form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg ATC: A10BH01
Manufacturer: Farmak JSC
-
The drug is intended for adults with type 2 diabetes mellitus to improve blood sugar control. It can be used either as monotherapy or in combination with other medications (e.g., metformin, insulin, or sulfonylurea).
Form: tablets, film-coated
Active substance Dosage sitagliptin 100 mg ATC: A10BH01
Manufacturer: Farmak JSC